Date of event
Tuesday, April 7, 2020 - 5:00 pm -
Tuesday, April 7, 2020 - 6:00 pm
Continuing Education Credits
None

Content Contributor

AASLD COVID-19 Working Group

Presenters

  • Oren K. Fix, MD, MSc, FAASLD
    Swedish Medical Center
  • Mark W. Russo, MD, MPH, FAASLD
    Carolinas Medical Center
  • Elizabeth C. Verna, MD, MS
    Columbia University Medical Center

Moderator / Presenter

  • Robert J. Fontana, MD, FAASLD
    University of Michigan Hospitals and Health

Panelists / Contributors

  • Jorge A. Bezerra, MD, FAASLD
    Cincinnati Children's Hospital Medical Center
  • Raymond T. Chung, MD, FAASLD
    Massachusetts General Hospital
  • Bilal Hameed, MD
    University of California, San Francisco
  • Ryan M. Kwok, MD
    Walter Reed National Military Medical Center
  • Brendan M. McGuire, MD
    University of Alabama at Birmingham
  • David C. Mulligan, MD, FAASLD
    Yale University
  • Daniel S. Pratt, MD, FAASLD
    Massachusetts General Hospital
  • K. Rajender Reddy, MD, FAASLD
    University of Pennsylvania Medical Center
  • Michael L. Schilsky, MD, FAASLD
    Yale New-Haven Hospital

Details

As the COVID-19 pandemic continues to evolve, AASLD is committed to helping our members and the broader community respond to increasing challenges and complexities.

This was the second in a series of webinars AASLD is dedicating to ongoing discoveries and discussions about COVID-19 and how it impacts the care of liver patients. This webinar:

Watch the Webinar / Download the Presentation

 

Download the slide presentation.

Presenter Bios

Oren K. Fix, MD, MSc, FAASLD

Dr. Oren Fix is the Medical Director of the Liver Transplant Program at Swedish Medical Center in Seattle, Washington and Clinical Associate Professor at the Washington State University Elson S. Floyd College of Medicine. He is an Associate Provider Informaticist at Providence St. Joseph Health and is board certified in Clinical Informatics and an Epic Physician Builder. He has served the AASLD as chair of the Training and Workforce and MOC Committees and currently serves on the Nominating Committee, Online Learning Committee, and the GI/Transplant Hepatology Pilot Steering Task Force. He is on the editorial boards of Liver Transplantation and Hepatology Communications. His research interests include alcohol-associated hepatitis and acute liver failure and he has more than 50 peer-reviewed publications and book chapters.

photo of Dr. Oren Fix


 

Mark W. Russo, MD, MPH, FAASLD

Mark W. Russo, MD, MPH, FAASLD is Medical Director of Liver Transplantation, Chief, Division of Hepatology, and Clinical Professor of Medicine at Carolinas Medical Center-Atrium Health. In the AASLD, Dr. Russo is Chair of the Maintenance of Certification Committee, member of the Nominating Committee, co-director of the 2020 AASLD Transplant Hepatology Board Review course, and member of a working group planning for the future hepatology workforce. He is an Associate Editor for the American Journal of Gastroenterology and serves on the editorial board of Expert Reviews in Gastroenterology and Hepatology and the Journal of Clinical Medicine. He has more than 100 peer-reviewed publications and editor of the textbook Diagnosis and Management of Autoimmune Hepatitis.

photo of Dr. Mark Russo


 

Elizabeth C. Verna, MD, MS

Dr. Elizabeth Verna is an Associate Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University, where she practices as transplant hepatologist. In addition, Dr. Verna has an active clinical research program in end-stage liver disease and liver transplantation and is the Director of Clinical Research for the Columbia University Transplant Clinical Research Center.

photo of Dr. Elizabeth Verna


 

Moderator Bio

Robert J. Fontana, MD, FAASLD

Dr. Fontana is a Professor of Medicine and Medical Director of Liver Transplantation at the University of Michigan. He is a clinical-translational investigator with research interests in viral hepatitis, drug induced liver injury and acute liver failure. He is co-chair of the Drug Induced Liver Injury Network (DILIN) Steering Committee and an active participant in the Hepatitis B Research Network. He has also been an active member of the US Acute Liver Failure Study Group since 1998 and is a current Co-PI of this multicenter network.

photo of Dr. Robert Fontana